Mark Voll's most recent trade in RenovoRx Inc was a trade of 80,000 Common Stock done . Disclosure was reported to the exchange on April 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| RenovoRx Inc | Mark Voll | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2026 | 80,000 | 117,380 | - | 0 | Common Stock | |
| RenovoRx Inc | Mark Voll | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2026 | 12,380 | 37,380 | - | 0 | Common Stock | |
| RenovoRx Inc | Mark Voll | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Mar 2026 | 97,200 | 97,200 | - | - | Common Stock | |
| RenovoRx Inc | Mark Voll | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Mar 2026 | 48,600 | 48,600 | - | - | Warrants |